The study also analyzed how drugmakers have implemented processes that comply with the Food and Drug Administration’s draft guidance issued in 2022 to improve diversity.
Genetics studies have a diversity problem that researches struggle to fix
While human beings of all races and ancestries are more than 99% genetically identical, even small differences in genes can spell big differences in health outcomes.
IPG Health launches clinical trial diversity offering
This offering from IPG Health will emphasize equality among several different aspects of diversity, including race, gender, age and other intersectional groups throughout the clinical trial process.
4 campaigns that show there’s no secret recipe to diversity
The ALA is embarking on this clinical trial diversity push with the backing of several notable pharma companies: Daiichi Sankyo, Genentech, Novartis, Novocure and Merck.
MM+M Podcast 5.17.23: ‘No quick solution’: Genentech’s Highsmith talks progress, challenges on road to DE&I
Jack O’Brien interviews Quita Highsmith, Genentech’s chief diversity officer, about findings from the biotech’s third annual D&I report. Lecia Bushak explains why the DEA is extending pandemic-era telehealth flexibility for accessing controlled substances.
A California physician training program adds diversity, but where do graduates end up?
Enrollment is up, but there is not enough long-term tracking to know whether these medical school graduates return to practice in regions where they’re most needed.
Tension builds in transgender policy debate in Montana